Telehealth support for caregivers of cancer patients
Official title: Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Run by Wake Forest University Health Sciences · NCT06709404 · Data updated 2026-11-12
This study tests if a telehealth support program can help caregivers of cancer patients feel less stressed about money and depression while improving their confidence and satisfaction in caring for their loved ones.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | January 31, 2025 |
| Main results expected | March 2027 |
| Study ends | March 2028 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06709404 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are primary caregivers of patients scheduled for CS+HIPEC who have access to technology and can provide informed consent.
✕Probably not a fit
Patients who do not have access to a computer or smartphone, or who are unable to understand English, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates a telehealth navigation intervention aimed at assisting primary caregivers of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC). The study focuses on reducing financial distress and depression while enhancing self-efficacy, satisfaction, and engagement in care. Participants are randomized into two groups: one receiving the telehealth intervention and the other receiving standard care. The study assesses various outcomes, including financial distress, quality of life, and community resource utilization over time.
Why it matters
Potential benefit: If successful, this intervention could significantly alleviate financial stress and improve the overall well-being of caregivers.
How similar studies have gone: Other studies have shown promise in using telehealth interventions to support caregivers, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Primary caregiver of a patient scheduled to receive CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center * Access to a computer or smartphone and must have an email address * 18 years of age or older at the time of consent * The ability to understand and willingness to provide written informed consent * The ability to read and write English Exclusion Criteria \- Patient declines access to their medical record
Where it's running
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Katie Duckworth — Wake Forest Baptist Comprehensive Cancer Center
- Study coordinator: Study Coordinator
- Email: Emily.Teal@advocatehealth.org
- Phone: 3367165772
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if virtual informed consent methods help people decide to join cancer research
This trial tests whether virtual human communicators and different consent messages can influence cancer patients’ understanding and willingness to participate in research.
-
AI-powered supportive care chatbot for young adult cancer survivors
A chatbot driven by artificial intelligence is tested to help young adult cancer survivors manage symptoms and care needs after treatment.
-
Telehealth pharmacist-led opioid education for cancer patients
This pilot tests a telehealth group education session led by a palliative care pharmacist to help adults with cancer use opioids more safely and effectively.
-
Mindfulness program to help with symptoms in chronic graft-versus-host disease
A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.
-
Non-invasive brain stimulation to help chemotherapy-induced nerve problems in cancer survivors
This trial tests whether a gentle brain stimulation method (tDCS) can help reduce numbness, tingling, and pain from CIPN in cancer survivors who are not currently in treatment.
-
Ambient sensor rooms to spot early problems in hospitalized cancer patients
This test will try whether special hospital rooms with cameras, microphones, and temperature sensors can help staff spot early delirium, falls, sleep problems, or mood changes in adults hospitalized with cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.